Astrana Health Revenue 2016-2026 | ASTH
Astrana Health revenue from 2016 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
|
Astrana Health Annual Revenue (Millions of US $) |
|
|---|---|
| 2025 | $3,182 |
| 2024 | $2,035 |
| 2023 | $1,387 |
| 2022 | $1,144 |
| 2021 | $774 |
| 2020 | $687 |
| 2019 | $561 |
| 2018 | $520 |
| 2017 | $356 |
| 2017 | $57 |
| 2016 | $306 |
| 2016 | $44 |
| 2015 | $33 |
| 2014 | $33 |
|
Astrana Health Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2026-06-30 | $973 |
| 2026-03-31 | $965 |
| 2025-12-31 | $951 |
| 2025-09-30 | $956 |
| 2025-06-30 | $655 |
| 2025-03-31 | $620 |
| 2024-12-31 | $665 |
| 2024-09-30 | $479 |
| 2024-06-30 | $486 |
| 2024-03-31 | $404 |
| 2023-12-31 | $353 |
| 2023-09-30 | $348 |
| 2023-06-30 | $348 |
| 2023-03-31 | $337 |
| 2022-12-31 | $294 |
| 2022-09-30 | $317 |
| 2022-06-30 | $270 |
| 2022-03-31 | $263 |
| 2021-12-31 | $195 |
| 2021-09-30 | $227 |
| 2021-06-30 | $176 |
| 2021-03-31 | $176 |
| 2020-12-31 | $177 |
| 2020-09-30 | $180 |
| 2020-06-30 | $165 |
| 2020-03-31 | $165 |
| 2019-12-31 | $179 |
| 2019-09-30 | $156 |
| 2019-06-30 | $130 |
| 2019-03-31 | $96 |
| 2018-12-31 | $107 |
| 2018-09-30 | $167 |
| 2018-06-30 | $123 |
| 2018-03-31 | $124 |
| 2017-12-31 | $120 |
| 2017-09-30 | $97 |
| 2017-06-30 | $81 |
| 2017-03-31 | $85 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $2.138B | $3.182B |
| Astrana Health is a provider-centric, technology-powered healthcare company. It operates an integrated healthcare delivery platform which enables providers to participate in value-based care arrangements. Astrana Health, formerly known as Apollo Medical Holdings Inc., is based in ALHAMBRA, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.581B | 13.26 |
| Quest Diagnostics (DGX) | United States | $27.271B | 23.22 |
| DaVita (DVA) | United States | $12.179B | 14.91 |
| Encompass Health (EHC) | United States | $12.036B | 20.89 |
| Elanco Animal Health (ELAN) | United States | $11.491B | 21.70 |
| Chemed (CHE) | United States | $6.620B | 23.60 |
| RadNet (RDNT) | United States | $6.069B | 175.27 |
| LifeStance Health (LFST) | United States | $4.991B | 100.46 |
| Option Care Health (OPCH) | United States | $3.523B | 14.89 |
| Aveanna Healthcare Holdings (AVAH) | United States | $3.123B | 21.68 |
| Addus HomeCare (ADUS) | United States | $2.164B | 19.57 |
| Pennant (PNTG) | United States | $1.396B | 36.34 |
| U.S Physical Therapy (USPH) | United States | $1.220B | 32.19 |
| Daxor (DXR) | United States | $0.065B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.024B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |